Fanzor
The Fanzor (Fz) protein is a eukaryotic, RNA-guided DNA endonuclease, which means it is a type of DNA cutting enzyme that uses RNA to target genes of interest.
≈ 3 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
The Fanzor (Fz) protein is a eukaryotic, RNA-guided DNA endonuclease, which means it is a type of DNA cutting enzyme that uses RNA to target genes of interest. In bacteria, RNA-guided DNA endonuclease systems, such as the CRISPR/Cas system, serve as an immune system to prevent infection by cutting viral genetic material.
Currently, CRISPR/Cas9-mediated's DNA cleavage has extensive application in biological research, and wide-reaching medical potential in human gene editing. Fanzor belongs to the OMEGA system. Evolutionarily, it shares a common ancestor, OMEGA TnpB, with the CRISPR/Cas12 system.
Due to the shared ancestry between the OMEGA system and the CRISPR system, the protein structure and DNA cleavage function of Fanzor and Cas12 remain largely conserved. Combined with the widespread presence of Fanzor across the diverse genomes of different eukaryotic species, this raises the possibility of OMEGA Fanzor being an alternative to CRISPR/Cas system with better efficiency and compatibility in other complex eukaryotic organisms, such as mammals.
Fanzor as a potential human genome editor
Due to its eukaryotic origin, the OMEGA Fanzor system may have some advantages over the better studied CRISPR/Cas gene editor in terms of human genome editing applications. In a CRISPR/Cas9 system, Cas9 proteins are guided by the guide RNA (gRNA) and protospacer adjacent motif (PAM) for DNA cleavage.
Interestingly, Fanzor genes in the soil fungus S. punctatus also contain non-coding sequences called ωRNA. Similar to CRISPR/Cas9, Fanzor protein is shown to cleave DNA in test tubes under the guidance of ωRNA and target-adjacent motif (TAM). In human cells, the Fanzor protein of Spizellomyces punctatus was successfully tested and shown to cleave DNA effectively.
However, its efficiency is lower compared to the closely related CRISPR/Cas12a system. By modifying and tweaking the ωRNA and the amino acid sequence, a second version of the S. punctatus Fanzor protein with improved cleavage efficiency - comparable to that of the CRISPR/Cas12a system - was engineered.
This shows that, with better modifications and more research, OMEGA Fanzor has the potential to match the CRISPR system in human genome editing in the future.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1359946110 under CC BY-SA 4.0; modifications have been made.